Latest Interviews
Showing 1–2 of 2 transcripts.
Clear all filters- a16z59 min
a16z Podcast | The Science and Business of Innovative Medicines
Jorge Conde, Vijay Pande, Sonal Chokshi, Vas Narasimhan
Novartis transformed its portfolio through a $50 billion restructuring that divested consumer healthcare to prioritize advanced therapies, data science, and proprietary platforms for cell and gene treatments. Under CEO Vas Narasimhan, the company enforces strict "standard of care" mandates for project approval, integrates market access early in development, and invested $15 billion to own specialized infrastructure while leveraging AI for financial forecasting and pathology analysis. This strategic pivot targets a 10% clinical success rate by shifting from bespoke drug development to modular platforms and dedicated digital innovation centers, positioning the firm to address undruggable targets and future modalities like xenotransplantation.
- a16z48 min
a16z Podcast | Getting Network Effects
Anu Hariharan, Jeff Jordan, Sonal Chokshi
The presentation defines genuine network effects as a metric of increasing user value and retention, distinguishing them from simple viral growth through case studies of Facebook, OpenTable, and Airbnb. It outlines specific bootstrapping strategies for marketplaces, including clustering tactics to achieve local density before scaling and methods like pre-population to avoid the "empty stadium" problem. Finally, the analysis examines how these structural advantages create defensible moats against competition, drive sustainable monetization, and influence resilience against external economic shocks.